Europe's overall Ukraine aid outpaces US by $26 billion, report says
Total assistance allocated by Europe to Ukraine since 2022 stands at 138 billion euros ($157 billion), 23 billion euros ($26 billion) more than the U.S., according to an April 15 report by the Kiel Institute for the World Economy's Ukraine Aid Tracker.
The U.S. still holds an edge in terms of military aid — its 65 billion euros ($74 billion) total leads Europe by 1 billion euros ($1.1 billion) — but the gap is narrowing, as Washington has not allocated a new aid package since Jan. 9, still under the Biden administration.
U.S. President Donald Trump has yet to provide fresh aid for Ukraine as he seeks to broker a ceasefire and restore ties with Moscow.
The U.S. president partially justified his reluctance to provide new aid by claiming that Europe has donated considerably less assistance to Ukraine while putting the U.S. aid at $350 billion, claims refuted by the Kiel Institute's report.
In March, the new administration even briefly paused all military and intelligence assistance previously approved by Biden to pressure Kyiv into accepting a mineral resources deal.
As a result, U.S. assistance to Ukraine has stalled since Trump took office, while Europe has steadily maintained its support. Ukraine previously experienced such a long gap in new U.S. aid allocations in early 2024 when a Trump-aligned wing of the Republican Party blocked the assistance in Congress.
Researchers highlighted several recent European aid packages, including Sweden's largest assistance tranche to date worth $1.6 billion and new support from Germany, the U.K., Norway, and Denmark.
Speaking at the 27th Ramstein-summit format on April 11, U.K. Defense Secretary John Healey announced that the allies — not including the U.S. — had committed more than 21 billion euros ($23.8 billion) in new security assistance to Kyiv.
Ukraine has ramped up calls for new aid, particularly air defense, as Russia continues in its unrelenting attacks against Ukrainian cities and rejects a temporary truce backed by Kyiv and Washington in March.
"The recent pause in U.S. aid raises the pressure on European governments to do more, both in financial and military assistance," Taro Nishikawa, project lead of the Ukraine Support Tracker at the Kiel Institute, said in a statement.
Researchers also highlighted the disparity between various European countries. Some of the larger Western economies, such as France, Italy, or Spain, have allocated notably smaller portions of their GDP than the Nordics and the Baltics, the report shows.
Read also: Ukraine war latest: Ukraine developing strategic-level air defense system; Russia intensifies assaults against Kharkiv Oblast
We've been working hard to bring you independent, locally-sourced news from Ukraine. Consider supporting the Kyiv Independent.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Washington Post
12 minutes ago
- Washington Post
Yemen's al-Qaida branch leader threatens Trump, Musk and others
DUBAI, United Arab Emirates — The leader of al-Qaida's Yemen branch has threatened both U.S. President Donald Trump and billionaire Elon Musk over the Israel-Hamas war in the Gaza Strip in his first video message since taking over the group last year. The half-hour video message by Saad bin Atef al-Awlaki, which spread online early Saturday via supporters of al-Qaida in the Arabian Peninsula, also included calls for lone-wolf militants to assassinate leaders in Egypt, Jordan and the Gulf Arab states over the war, which has decimated Gaza. The video of al-Awlaki's speech showed images of Trump and Musk, as well as U.S. Vice President JD Vance, Secretary of State Marco Rubio and Secretary of State Pete Hegseth. It also included images of logos of Musk's businesses, including the electric carmaker Tesla. 'There are no red lines after what happened and is happening to our people in Gaza,' al-Awlaki said. 'Reciprocity is legitimate.' Though believed to be weakened in recent years due to infighting and suspected U.S. drone strikes killing its leaders, the group known by the acronym AQAP had been considered the most dangerous branch of al-Qaida still operating after the 2011 killing by U.S. Navy SEALs of founder Osama bin Laden , who masterminded the Sept. 11, 2001, attacks. In 2022, a U.S. drone strike in Afghanistan killed bin Laden's successor, Ayman al-Zawahri , who also helped plot 9/11. The Sept. 11 attacks then began decades of war by the U.S. in Afghanistan and Iraq, and fomented the rise of the Islamic State group. Al-Awlaki already has a $6 million U.S. bounty on his head, as Washington says al-Awlaki 'has publicly called for attacks against the United States and its allies.' He replaced AQAP leader Khalid al-Batarfi, whose death was announced by the group in 2024. AQAP seizing onto the Israel-Hamas war follows the efforts of Yemen's Houthi rebels to do the same. The Iranian-backed group has launched missile attacks on Israel and targeted commercial vessels moving through the Red Sea corridor, as well as American warships. The U.S. Navy has described their campaign against the Houthis as the most intense combat it has faced since World War II. The Trump administration also launched its own intense campaign of strikes on the Houthis, which only ended before the president's recent trip to the Middle East . The Houthis' international profile rose as the group remains mired in Yemen's long-stalemated war. Al-Awlaki may be betting on the same for his group, which U.N. experts have estimated has between 3,000 and 4,000 active fighters and passive members. The group raises money by robbing banks and money exchange shops, as well as smuggling weapons, counterfeiting currencies and ransom operations, according to the U.N. The Shiite Zaydi Houthis have previously denied working with AQAP, a Sunni extremist group. However, AQAP targeting of the Houthis has dropped in recent years, while the militants keep attacking Saudi-led coalition forces who have battled the Houthis. 'As the Houthis gain popularity as leaders of the 'Arab and Muslim world's resistance' against Israel, al-Awlaki seeks to challenge their dominance by presenting himself as equally concerned about the situation in Gaza,' said Mohammed al-Basha, a Yemen expert of the Basha Report risk advisory firm. 'For a national security and foreign policy community increasingly disengaged from Yemen, this video is a clear reminder: Yemen still matters.'
Yahoo
14 minutes ago
- Yahoo
Sanofi (SNY) Stock Down 5% Despite AERIFY-1 Success
Sanofi (NASDAQ:SNY)'s shares fell 5% this week, even as the company announced positive results from its AERIFY-1 trial with Regeneron Pharmaceuticals, marking a significant advance in COPD treatment. This decline comes in contrast to a 2% rise in the broader market, suggesting that investors may be focusing on other company initiatives, such as SNY's recent partnership with Stagecoach Performing Arts to raise awareness about Type 1 diabetes. Despite the short-term drop, Sanofi (NASDAQ:SNY)'s long-term performance remains strong. Over the past five years, the company has delivered a total return of 19.59%, outpacing both the French Pharmaceuticals sector and the broader market, which saw declines of 4% and 4.5% respectively in the past year. Analysts remain optimistic about Sanofi (NASDAQ:SNY)'s future, with the current share price at €95.9 and a consensus target of €117.17, an 18.5% potential upside. The company's Projections for 2028 include revenues of €51.2 billion and earnings of €10.2 billion, supported by innovative drug development and efficient operations. While we acknowledge the potential of SNY as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: and Disclosure: None.
Yahoo
14 minutes ago
- Yahoo
Viatris (VTRS) Faces Securities Fraud Class Action Over FDA Inspection Fallout
On May 31, 2025, Viatris Inc. (NASDAQ:VTRS) became the subject of a securities fraud class action lawsuit filed in the U.S. District Court for the Western District of Pennsylvania. The suit alleges that between August 8, 2024, and February 26, 2025, the company and certain executives made materially false or misleading statements regarding the operational status of its Indore, India manufacturing facility. Ralf Kleemann/ The complaint centers on Viatris' public assurances that its facilities were in "good operating condition" and committed to "the highest quality manufacturing standards." However, following a failed inspection, the U.S. Food and Drug Administration issued a Warning Letter and Import Alert in December 2024 that affected 11 products, including the cancer drug Lenalidomide. On February 27, 2025, Viatris (NASDAQ:VTRS) disclosed that the inspection issues would negatively impact 2025 revenue by roughly $500 million and earnings from operations by about $385 million. This revelation led to a 15% drop in Viatris' stock price, from $11.24 to $9.53 per share. Investors who purchased Viatris securities during the specified period have until June 3, 2025, to seek appointment as lead plaintiff in the lawsuit. While we acknowledge the potential of VTRS as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires. Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data